Clinical trial
Study on the Mechanism of Prevotella Copri Promoting the Occurrence and Development of Atherosclerosis
NCT06047249 is registered in ClinicalTrials.gov with Hai Tian as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on the Mechanism of Prevotella Copri Promoting the Occurrence and Development of Atherosclerosis
- Lead sponsor
- Hai Tian
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 23, 2022
- Completion date
- July 7, 2024
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.